LPTX
Leap Therapeutics (LPTX)
$46
About Leap Therapeutics (LPTX)
Leap Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted and immuno-oncology therapeutics. Its novel therapies are designed to treat patients with cancer. The company was founded on January 3, 2011 and is headquartered in Cambridge, MA.
Details
Daily high
$0.50
Daily low
$0.45
Price at open
$0.46
52 Week High
$3.61
52 Week Low
$0.22
Market cap
26.0M
Dividend yield
0.00%
Volume
33,761
Avg. volume
1.4M
P/E ratio
-.29
Leap Therapeutics News
Details
Daily high
$0.50
Daily low
$0.45
Price at open
$0.46
52 Week High
$3.61
52 Week Low
$0.22
Market cap
26.0M
Dividend yield
0.00%
Volume
33,761
Avg. volume
1.4M
P/E ratio
-.29